408-9, Platinum Business Centre, Dubai
PhonePhone: UAE : 8004425433 / KSA : 8004400200
Show Menu

TaqPath™ Seq HIV-1 Genotyping Kit

Detecting genomic mutations in three main antiretroviral drug classes to aid the monitoring and treatment of HIV-1 infected individuals.

HIV-1 Genotyping for drug resistance testing

Intended Use:

  • Sanger sequencing-based in vitro diagnostics (IVD) assay
  • Aids in detecting genomic mutations in the protease, reverse transcriptase and integrase regions of the pol gene
  • Uses HIV-1 viral ribonucleic acid extracted from EDTA plasma and dried blood spots
  • Intended as an aid in the monitoring and treatment of HIV-1 infected individuals
  • Validated on 3500-Series Genetic Analyzers
  • Provides results for a broad range of HIV-1 Group M subtypes of global significance

What it is:

  • Complete gold-standard Sanger sequencing technology-based kit for HIV-1 genotyping for detection of drug resistance mutations
  • Addresses protease, reverse transcriptase and integrase regions of the HIV-1 pol gene
  • Enhances Group M subtype coverage to address global and local testing needs
  • Builds on Applied Biosystems two-decade legacy in HIV-1 genotyping beginning with ViroSeq

Why it matters:

  • An opportunity to make HIV-1 genotyping accessible to all for both public health surveillance and individual-level drug resistance testing
  • Allows for global standardization of HIV-1 genotyping testing for improved quality and intercomparability of results.

Product details

TaqPath Seq HIV-1 Genotyping Kit – designed for the evolving needs of HIV-1 drug resistance testing


TaqPath Seq HIV-1

Request More Info

    search PRODUCTS

    ^
    Show Buttons
    Share On Twitter
    Hide Buttons